This site is intended for healthcare professionals
News

Spectrum Pharmaceuticals announces that the FDA is deferring its action on the BLA for Rolontis to treat neutropenia.

Read time: 1 mins
Last updated:27th Oct 2020
Published:27th Oct 2020
Condition: Neutropenia
Type: drug
Register free for full access to medthority.com